Search Results
Mar 18, 2026, 11:07 ET reVolver Podcasts Lanza el Podcast "Mr. Irrelevant ™", Presentado por el Veterano Locutor Josh Lewin.
More news about: reVolver Podcasts
![S&P Dow Jones Indices Licenses S&P 500® to Trade[XYZ] for Perpetual Contracts on Hyperliquid](https://mma.prnewswire.com/media/1854673/SPDJI_Logo.jpg?w=300){kind=logo}
Mar 18, 2026, 09:30 ET S&P Dow Jones Indices Licenses S&P 500® to Trade[XYZ] for Perpetual Contracts on Hyperliquid
Jones Indices LLC or its affiliates ("SPDJI") and has been licensed for use by Trade[XYZ] ("XYZ"). S&P®, S&P 500®, SPX®, SPY®, The 500®, U.S. 500™, SP™ are trademarks of Standard & Poor's Financial Services LLC ("S&P"); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings
More news about: S&P Dow Jones Indices
Mar 18, 2026, 06:00 ET Pizza Hut Goes Full-Court Press for March Madness® with Slam-Dunk Space Jam™ Collab and New Menu Drop
& delivery fees not included. The Pizza Hut name, logos & related marks are trademarks of Pizza Hut, LLC. © 2026 Pizza Hut, LLC. © & ™ Warner Bros. Entertainment Inc.** NO PURCHASE NECESSARY. Open to legal residents of the 50 U.S. and D.C., 18+. Must be a member of the Hut
More news about: Pizza Hut
Mar 17, 2026, 19:15 ET AI Monster, Inc., an Ethically Sourced Data Company, Emerges from Stealth
www.aimonster.ai.About AI MonsterAI Monster is an ethically sourced data company with an AI Center of Excellence (CoE) platform―The MonsterSphere TM ―that turns human expertise and judgement about AI into trusted, machine-readable insights by job function, at scale.AI Monster aims to power
More news about: AI MONSTER, INC.
Mar 17, 2026, 10:15 ET Centera Photonics Announces First 1.6Tbps DR8 LPO Transceiver based on NewPhotonics® LPO+™ PIC with Integrated OSPic™ Optical Signal Processor
solution provider for data center interconnect, today announced its first 1.6Tbps DR8 LPO transceiver module featuring the NewPhotonics® NPG10203 1.6T LPO+™ PIC with integrated lasers, modulators, and OSPic™ optical signal processor.
More news about: Centera Photonics
Mar 17, 2026, 09:02 ET ISPE Announces its 2026 ISPE Europe Annual Conference Keynote Speakers
Digital Compliance by DesignGood Engineering Practices (GEP) and Good Manufacturing Practices (GMP)-Compliant Project DeliveryPharma 4.0™ in ActionRegulatory and QualitySustainability and Substances of ConcernThe 2026
More news about: ISPE
Mar 17, 2026, 09:00 ET Wilkerson Crane Rental Announces Strategic Investment from NewMile Capital and Haywood Lane to Accelerate Growth
operational capabilities so we can deliver even greater value to our customers while maintaining the safety and service standards that define Wilkerson."TM Capital served as exclusive financial advisor to Wilkerson Crane Rental. Crown CFO served as an advisor, and Lathrop GPM LLP served as legal counsel
More news about: NewMile Capital LLC
Mar 17, 2026, 09:00 ET Apertura Gene Therapy and Viralgen Announce Strategic Collaboration to Manufacture TfR1 CapX, a Next-Generation Capsid for Gene Therapies Designed to Treat Central Nervous System Diseases
the Bayer AG group, Viralgen delivers end-to-end support from early development to large-scale commercial manufacturing. Leveraging their proprietary Pro10™ suspension cell line and Aava™ manufacturing platform, Viralgen achieves industry-leading, high-yield, scalable manufacturing across all AAV serotypes.
More news about: Viralgen
Mar 17, 2026, 09:00 ET Apertura Gene Therapy and Viralgen Announce Strategic Collaboration to Manufacture TfR1 CapX, a Next-Generation Capsid for Gene Therapies Designed to Treat Central Nervous System Diseases
the Bayer AG group, Viralgen delivers end-to-end support from early development to large-scale commercial manufacturing. Leveraging their proprietary Pro10™ suspension cell line and Aava™ manufacturing platform, Viralgen achieves industry-leading, high-yield, scalable manufacturing across all AAV serotypes.
More news about: Viralgen
Mar 17, 2026, 09:00 ET Apertura Gene Therapy und Viralgen kündigen strategische Zusammenarbeit zur Herstellung von TfR1 CapX an, einem Kapsid der nächsten Generation für Gentherapien zur Behandlung von Erkrankungen des zentralen Nervensystems
AG-Konzerns gegründet und bietet End-to-End-Unterstützung von der frühen Entwicklung bis zur großtechnischen Herstellung. Mit der firmeneigenen Pro10™-Suspensionszelllinie und der Aava™-Herstellungsplattform erreicht Viralgen eine branchenführende, hochproduktive und skalierbare Herstellung für alle AAV-Serotypen.
More news about: Viralgen
Mar 17, 2026, 09:00 ET Apertura Gene Therapy y Viralgen anuncian una colaboración estratégica para la fabricación de TfR1 CapX
Viralgen ofrece soporte integral desde el desarrollo inicial hasta la fabricación comercial a gran escala. Gracias a su línea celular en suspensión Pro10™ y a la plataforma de fabricación Aava™, Viralgen logra una fabricación escalable, de alto rendimiento y líder en la industria para todos los serotipos
More news about: Viralgen
Mar 17, 2026, 09:00 ET Apertura Gene Therapy et Viralgen annoncent une collaboration stratégique pour la fabrication de TfR1 CapX, une capside de nouvelle génération pour les thérapies géniques destinées à traiter les maladies du système nerveux central.
soutien de bout en bout, du développement précoce à la fabrication commerciale à grande échelle. En s'appuyant sur sa lignée cellulaire en suspension Pro10™ propriétaire et sa plateforme de fabrication Aava™, Viralgen réalise une fabrication évolutive à haut rendement, à la pointe de l'industrie, pour tous
More news about: Viralgen
Mar 17, 2026, 08:31 ET The Odor Doctors Introduce Odor15™: A Fast, Professional Vehicle Odor Elimination System Designed for Speed, Safety, and Proven Results
introduce chemical exposure concerns. By contrast, the Odor15™ system is designed to neutralize vehicle odors in approximately 15 minutes, allowing operators to move vehicles through the reconditioning process quickly.Odor15™ was developed by the experts behind The Odor Doctors,
More news about: The Odor Doctors
Mar 17, 2026, 08:00 ET G-P Gia™ Wins H3 HR Advisors HCM Technology Signal Award for AI Maturity
largest team of in-country HR, legal, and compliance experts, and its unmatched proprietary knowledge base.G-P: Global Made Possible ™To learn more, please visit: g-p.com or connect with us via
More news about: G-P
Mar 17, 2026, 08:00 ET G-P Gia™ Wins H3 HR Advisors HCM Technology Signal Award for AI Maturity
largest team of in-country HR, legal, and compliance experts, and its unmatched proprietary knowledge base.G-P: Global Made Possible ™To learn more, please visit: g-p.com or connect with us via
More news about: G-P
Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia submissão regulatória suplementar de MINJUVI® (tafasitamabe) para linfoma folicular na Argentina e no México
2013;31:3272-3278.Sehn LH, Luminari S, Scholz CW, Hübel K, Salar A, Paneesha S, Wahlin BE, Panayiotidis P, Lee HP, Jiménez Ubieto A, Sancho JM, Kim TM, Domingo Domenech E, Kumode T, Poh C, Thieblemont C, Deeren D, de Wit E, Arbushites M, Casadebaig ML, Trneny M. Tafasitamab plus lenalidomide and rituximab
More news about: Knight Therapeutics Inc.
Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia la presentación regulatoria complementaria de MINJUVI® (tafasitamab) para linfoma folicular en Argentina y México
2013;31:3272-3278.Sehn LH, Luminari S, Scholz CW, Hübel K, Salar A, Paneesha S, Wahlin BE, Panayiotidis P, Lee HP, Jiménez Ubieto A, Sancho JM, Kim TM, Domingo Domenech E, Kumode T, Poh C, Thieblemont C, Deeren D, de Wit E, Arbushites M, Casadebaig ML, Trneny M. Tafasitamab plus lenalidomide and rituximab
More news about: Knight Therapeutics Inc.
Mar 17, 2026, 07:35 ET Knight Therapeutics Anuncia Aprovação de Indicação Adicional para MINJUVI® (tafasitamabe) no Brasil
https://www.orpha.net/en/disease/detail/545Sehn LH, Luminari S, Scholz CW, Hübel K, Salar A, Paneesha S, Wahlin BE, Panayiotidis P, Lee HP, Jiménez Ubieto A, Sancho JM, Kim TM, Domingo Domenech E, Kumode T, Poh C, Thieblemont C, Deeren D, de Wit E, Arbushites M, Casadebaig ML, Trneny M. Tafasitamab plus lenalidomide and rituximab
More news about: Knight Therapeutics Inc.
Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia la aprobación de una indicación adicional para MINJUVI® (tafasitamab) en Brasil
https://www.orpha.net/en/disease/detail/545Sehn LH, Luminari S, Scholz CW, Hübel K, Salar A, Paneesha S, Wahlin BE, Panayiotidis P, Lee HP, Jiménez Ubieto A, Sancho JM, Kim TM, Domingo Domenech E, Kumode T, Poh C, Thieblemont C, Deeren D, de Wit E, Arbushites M, Casadebaig ML, Trneny M. Tafasitamab plus lenalidomide and rituximab
More news about: Knight Therapeutics Inc.
Mar 17, 2026, 00:00 ET Sony Semiconductor Solutions to Release 4K Image Sensor for Security Cameras with the Industry's Smallest 1.45 µm LOFIC Pixels
image sensors that can provide stable and high-quality imaging in conditions from bright to dark continues to grow.The IMX908 employs STARVIS 3™, Sony's proprietary LOFIC pixel technology developed for security cameras. It enables nearly 20x the amount of saturated charge as conventional products*4
More news about: Sony Semiconductor Solutions Corporation
Mar 16, 2026, 16:35 ET GMI Cloud Bringing NVIDIA Vera Rubin NVL72™ Online in Global Sovereign AI Initiative
NVIDIA Vera Rubin NVL72™ online, establishing a standard for national-scale artificial intelligence deployments. This initiative for sovereign AI Factory buildouts is already
More news about: GMI Cloud
Mar 16, 2026, 13:14 ET Vorbeck Materials Named Gold Sponsor of the Congressional Fire Services Institute
they're on the line. We've closed that gap, and CFSI is the right place to introduce Vorbeck O3™ to the leaders who need it most."Introducing Vorbeck O3™: Setting the New American StandardVorbeck O3™ is a breakthrough in firefighting foam technology. Engineered for emergency response to
More news about: Vorbeck Materials
Mar 16, 2026, 11:19 ET Valvoline Premium Blue One Solution Gen 2 Sets New Benchmark for Engine Protection, Uptime and Operational Efficiency
LinkedIn.™™ Trademark, Valvoline Global or its subsidiaries, registered in various countries
More news about: Valvoline Global Operations
Mar 16, 2026, 09:00 ET Enchant Your Cup with Harry Potter® and Coffee mate® at The Butterbeer Cafe in NYC
www.harrypotter.com.All characters and elements © & ™ Warner Bros. Entertainment Inc. Publishing Rights © JKR. (s25)About Warner Bros. Discovery Global Consumer ProductsWarner Bros.
More news about: Coffee mate®
Mar 16, 2026, 08:05 ET Dow to participate at the 2026 J.P. Morgan Industrials Conference
http://instagram.com/dow_official®TM Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow
More news about: The Dow Chemical Company